Skip to content

Study of T-PRED(TM) Compared to Pred Forte(R)

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00699803
Enrollment
64
Registered
2008-06-18
Start date
2008-05-31
Completion date
2008-08-31
Last updated
2020-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

Study of T-PRED(TM) compared to Pred Forte(R)

Interventions

DRUGT-PRED

T-PRED sterile ophthalmic solution

Pred Forte sterile ophthalmic solution

Sponsors

Bausch & Lomb Incorporated
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age

Exclusion criteria

* No active or adverse disease

Design outcomes

Primary

MeasureTime frame
Mean Aqueous Humor Prednisolone Acetate Concentration4 hours

Countries

United States

Participant flow

Participants by arm

ArmCount
T-Pred
Tobramycin prednisolone acetate combination T-PRED: sterile ophthalmic solution
32
Pred Forte
Prednisolone acetate Pred Forte: sterile ophthalmic solution
32
Total64

Baseline characteristics

CharacteristicT-PredPred ForteTotal
Age, Continuous66.6 years
STANDARD_DEVIATION 10
65.7 years
STANDARD_DEVIATION 10.9
66.1 years
STANDARD_DEVIATION 10.4
Sex: Female, Male
Female
19 Participants23 Participants42 Participants
Sex: Female, Male
Male
13 Participants9 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 32
other
Total, other adverse events
0 / 320 / 32
serious
Total, serious adverse events
0 / 320 / 32

Outcome results

Primary

Mean Aqueous Humor Prednisolone Acetate Concentration

Time frame: 4 hours

Population: Analysis Population was defined as all participants who received investigational product and on whom successful anterior chamber tap were performed at the designated time point

ArmMeasureValue (MEAN)Dispersion
T-PredMean Aqueous Humor Prednisolone Acetate Concentration102.5 ng/mLStandard Deviation 5.6
Pred ForteMean Aqueous Humor Prednisolone Acetate Concentration127.5 ng/mLStandard Deviation 66.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026